Loss of heterozygosity in tumour-adjacent normal tissue of breast and bladder cancer

被引:66
作者
Försti, A [1 ]
Louhelainen, J
Söderberg, M
Wijkström, H
Hemminki, K
机构
[1] Karolinska Inst, Novum, Dept Biosci, S-14157 Huddinge, Sweden
[2] Huddinge Hosp, Dept Pathol, S-14186 Huddinge, Sweden
[3] Huddinge Hosp, Dept Urol, S-14186 Huddinge, Sweden
关键词
loss of heterozygosity; normal tissue; breast cancer; bladder cancer;
D O I
10.1016/S0959-8049(01)00118-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Normal tumour-adjacent breast tissue samples from 12 breast cancer patients forming six monozygotic twin pairs were analysed for loss of heterozygosity (LOH) on chromosomes 1, 13 and 17. 7 patients showed LOH at one or more markers. Each of them had a different LOH pattern. Only one twin pair showed LOH at the same locus, but the twins had lost a different allele. Multiple (n=1-13), histologically. normal samples were collected from 6 bladder cancer patients and analysed for LOH on chromosomes 3 and 9. On chromosome 9, all 6 patients analysed showed LOH in at least one sample and one marker. Four of them also showed LOH on chromosome 3. Samples surrounding different tumours of a given patient resembled each other. More heterogeneity was seen between the patients, even though they shared some similarities in LOH clustering. The results demonstrate that tumour-adjacent normal tissues already harbour genetic changes typical for tumours. These alterations can reveal the earliest changes leading to tumorigenesis. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1372 / 1380
页数:9
相关论文
共 49 条
[41]   Four tumor suppressor loci on chromosome 9q in bladder cancer: evidence for two novel candidate regions at 9q22.3 and 9q31 [J].
Simoneau, M ;
Aboulkassim, TO ;
LaRue, H ;
Rousseau, F ;
Fradet, Y .
ONCOGENE, 1999, 18 (01) :157-163
[42]  
SPRUCK CH, 1994, CANCER RES, V54, P784
[43]  
STEINECK G, 1996, DIS KIDNEY
[44]  
Vieten L, 1998, GENE CHROMOSOME CANC, V21, P39, DOI 10.1002/(SICI)1098-2264(199801)21:1<39::AID-GCC6>3.0.CO
[45]  
2-9
[46]   P53 ACTIVATES EXPRESSION OF HIC-1, A NEW CANDIDATE TUMOR-SUPPRESSOR GENE ON 17P13.3 [J].
WALES, MM ;
BIEL, MA ;
ELDEIRY, W ;
NELKIN, BD ;
ISSA, P ;
CAVENEE, WK ;
KUERBITZ, SJ ;
BAYLIN, SB .
NATURE MEDICINE, 1995, 1 (06) :570-577
[47]   Sequential molecular abnormalities are involved in the multistage development of squamous cell lung carcinoma [J].
Wistuba, II ;
Behrens, C ;
Milchgrub, S ;
Bryant, D ;
Hung, J ;
Minna, JD ;
Gazdar, AF .
ONCOGENE, 1999, 18 (03) :643-650
[48]  
Wu Q, 1996, INT J CANCER, V65, P840, DOI 10.1002/(SICI)1097-0215(19960315)65:6<840::AID-IJC22>3.0.CO
[49]  
2-6